Northwire Canada EditionSaturday, July 18, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 119
  1. Oct 16, 2025 · 07:30 · APS

    Aptose's Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML

    Aptose's Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML

    01
  2. Oct 16, 2025 · 04:00 · RKV

    None

    Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference

    02
  3. Oct 15, 2025 · 21:04 · IOT

    Innovotech makes strategic investments to expand analytical laboratory services and offers an unsecured convertible debenture for $200,000.

    Innovotech makes strategic investments to expand analytical laboratory services and offers an unsecured convertible debenture for $200,000.

    03
  4. Oct 15, 2025 · 20:06 · HEM

    Hemostemix seeks to treat refractory angina

    Hemostemix seeks to treat refractory angina

    04
  5. Oct 15, 2025 · 19:55 · INNO

    Innocan receives LPT-CBD patent allowance in Japan

    Innocan receives LPT-CBD patent allowance in Japan

    05
  6. Oct 15, 2025 · 17:13 · PHRM

    None

    Pharmather touts "discovery platform" KetAImine

    06
  7. Oct 15, 2025 · 16:57 · AIDR

    Rocket Doctor's Treatment receives $2M (U.S.) grant

    Rocket Doctor's Treatment receives $2M (U.S.) grant

    07
  8. Oct 15, 2025 · 16:09 · CHS

    None

    Comprehensive Healthcare signs 5-year partnership MOU

    08
  9. Oct 15, 2025 · 16:01 · VIVI

    Canadian Securities Exchange Welcomes Listing of TempraMed Technologies Ltd.

    Canadian Securities Exchange Welcomes Listing of TempraMed Technologies Ltd.

    09
  10. Oct 15, 2025 · 16:00 · INNO

    Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan

    Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan

    10
  11. Oct 15, 2025 · 15:52 · HEM

    Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

    Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

    11
  12. Oct 15, 2025 · 13:55 · AGN

    Algernon Pharmaceuticals completes name change

    Algernon Pharmaceuticals completes name change

    12
  13. Oct 15, 2025 · 08:02 · PHRM

    PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings

    PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings

    13
  14. Oct 15, 2025 · 08:00 · AIDR

    None

    NIH Awards US$2M Small Business Innovation grant to Transform How AI Collects Medical History

    14
← Newer Older →